BeOne Medicines AG
688235Biotechnology
CN¥253.69−0.28%As of Oct 29vs prior close
- Market cap
- $4.4B
- P/E (TTM)
- –
- From 52W high
- −19.03%
- EPS (FY25)
- $0.19
- Revenue (LTM)
- $6.1B
- Net margin
- 10.70%
Nomior Score
50
Anchored CompounderTop 50% of the scored universe
Growth67
Quality67
Value—
Momentum18
Resilience53
Growth
+157.59%revenue a year over 9 fiscal years
FY16 $1.1MLTM $6.1B
Connections
Revenue to profitQ2 FY26
14% of revenue became net profit, up 7 pts on a year.